Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

This study has been completed.
Information provided by:
Roswell Park Cancer Institute Identifier:
First received: November 1, 1999
Last updated: March 3, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: January 2000 (Final data collection date for primary outcome measure)